logo
Home
Publications
About the Authors
About the Authors
This site complies with the
HONcode standard for trustworthy health
information:
verify here.
Deutsch
Englisch
Contact
Impressum
Data Protection
Login
logo
Home
Publications
About the Authors
About the Authors
This site complies with the
HONcode standard for trustworthy health
information:
verify here.
Deutsch
Englisch
Contact
Impressum
Data Protection
Login
Dippel, Franz-Werner
Sanofi-Aventis Deutschland GmbH
Publications:
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.